These changes allow researchers to study amylin receptor signaling and related metabolic pathways over longer timeframes than would be possible with endogenous amylin alone [1]
These have been shown in models of muscle injury, tendon degeneration, and experimental colitis
It has not been approved by the FDA or any other regulatory authority for medical or clinical use
[1] These are meaningful cosmetic endpoints, and they map logically onto the mechanism: more collagen and glycosaminoglycan synthesis, better-organized remodeling, and reduced oxidative and inflammatory burden should, in principle, translate into firmer, smoother, more resilient skin
Note: Adults under 130 lbs may benefit from using a 29G " or 25G 5/8" needle to achieve intramuscular delivery, based on injection site and medical advice